Price
$2.94
Decreased by -0.68%
Dollar volume (20D)
34.38 K
ADR%
6.27
Earnings report date
Nov 12, 2025
Shares float
10.87 M
Shares short
36.75 K [0.34%]
Shares outstanding
36.23 M
Market cap
106.52 M
Beta
1.10
Price/earnings
N/A
20D range
2.40 3.14
50D range
1.93 3.14
200D range
0.90 3.14

Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide.

It develops its products using its proprietary bacteriophage-based technology.

The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia.

It has research collaboration agreement with Merck Sharp & Dohme Corp. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents.

The company is based in Los Angeles, California.

Armata Pharmaceuticals, Inc. operates as a subsidiary of Innoviva, Inc.

Reported date EPSChange YoY EstimateSurprise
Aug 12, 25 -0.45
Decreased by -280.00%
-0.39
Decreased by -15.38%
May 5, 25 -0.20
Increased by +71.41%
-0.38
Increased by +48.08%
Mar 19, 25 -0.23
Increased by +57.87%
-0.35
Increased by +33.80%
Nov 12, 24 -0.15
Increased by +80.00%
-0.28
Increased by +46.43%
Aug 13, 24 0.25
Increased by +350.00%
-0.44
Increased by +156.82%
May 7, 24 -0.69
Decreased by -72.50%
-0.31
Decreased by -122.58%
Mar 21, 24 -0.55
Decreased by -89.66%
-0.35
Decreased by -57.14%
Nov 14, 23 -0.75
Decreased by -212.50%
-0.31
Decreased by -141.94%
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Jun 30, 25 2.17 M
Increased by +N/A%
-16.30 M
Decreased by -281.34%
Decreased by -751.27%
Decreased by N/A%
Mar 31, 25 491.00 K
Decreased by -49.17%
-6.53 M
Increased by +73.90%
Decreased by -1.33 K%
Increased by +48.65%
Dec 31, 24 1.24 M
Decreased by -19.18%
2.60 M
Increased by +113.10%
Increased by +210.53%
Increased by +116.21%
Sep 30, 24 2.97 M
Increased by +142.69%
-5.48 M
Increased by +82.41%
Decreased by -184.36%
Increased by +92.75%
Jun 30, 24 0.00
Decreased by -100.00%
8.99 M
Increased by +353.34%
Increased by +N/A%
Increased by +N/A%
Mar 31, 24 966.00 K
Increased by +21.36%
-25.02 M
Decreased by -72.68%
Decreased by -2.59 K%
Decreased by -42.29%
Dec 31, 23 1.53 M
Increased by +45.39%
-19.85 M
Decreased by -92.67%
Decreased by -1.30 K%
Decreased by -32.52%
Sep 30, 23 1.23 M
Decreased by -8.45%
-31.16 M
Decreased by -262.13%
Decreased by -2.54 K%
Decreased by -295.53%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY